Vora, Pratik A; Patel, Rakesh; Dharamsi, Abhay
(Recent Patents on Anti-Cancer Drug Discovery | Volume 15 | Issue 2, 2020)
Background: Bortezomib is a reversible inhibitor of proteasome proteins in mammalian cells. Bortezomib is proven to be cytotoxic to a number of tumor cells by disrupting their normal homeostatic mechanism and thereby, ...